Literature DB >> 323439

Pancreatic alpha and beta cell functions in cystic fibrosis.

B M Lippe, M A Sperling, R R Dooley.   

Abstract

Insulin and glucagon secretions were studied during oral glucose tolerance testing and arginine infusion in 13 patients with cystic fibrosis. Two groups of patients were identified; Group I (N=6) whose OGTT was entirely normal and Group II (N=7) who had some abnormality in glucose during OGTT. In each group basal glucagon concentrations were normal and supressed appropriately (p less than 0.05) after glucose; insulin responses were attenuated and the peak responses delayed. During arginine stimulation, insulin secretion was impaired in each group. However, glucagon secretion was diminished only in Group II. Thus, insulinopenia was found in both groups and hyperglucagonemia was not found as a contributory factor to the hyperglycemia in Group II.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 323439     DOI: 10.1016/s0022-3476(77)81241-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  17 in total

Review 1.  Understanding cystic-fibrosis-related diabetes: best thought of as insulin deficiency?

Authors:  Lee Dobson; Christopher D Sheldon; Andrew T Hattersley
Journal:  J R Soc Med       Date:  2004       Impact factor: 5.344

2.  Glucose tolerance in cystic fibrosis.

Authors:  S Lanng; B Thorsteinsson; G Erichsen; J Nerup; C Koch
Journal:  Arch Dis Child       Date:  1991-05       Impact factor: 3.791

3.  Prevalence of diabetes mellitus and impaired glucose tolerance in cystic fibrosis.

Authors:  A Carroccio; L Iapichino; G Montalto; F Pardo; G Iacono; M Soresi; M Collura; A Notarbartolo
Journal:  Acta Diabetol Lat       Date:  1990 Oct-Dec

Review 4.  Diagnosis, screening, and management of cystic fibrosis-related diabetes.

Authors:  Antoinette Moran
Journal:  Curr Diab Rep       Date:  2002-04       Impact factor: 4.810

5.  Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress.

Authors:  Thierry Ntimbane; Blandine Comte; Geneviève Mailhot; Yves Berthiaume; Vincent Poitout; Marc Prentki; Rémi Rabasa-Lhoret; Emile Levy
Journal:  Clin Biochem Rev       Date:  2009-11

6.  Cystic fibrosis-related diabetes in adults: inpatient management of 121 patients during 410 admissions.

Authors:  Neda Rasouli; Stacey Seggelke; Joanna Gibbs; R Matthew Hawkins; Matthew L Casciano; Elizabeth Cohlmia; Jennifer Taylor-Cousar; Cecilia Wang; Rocio Pereira; Elisa Hsia; Boris Draznin
Journal:  J Diabetes Sci Technol       Date:  2012-09-01

Review 7.  Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review.

Authors:  Antoinette Moran; Dorothy Becker; Samuel J Casella; Peter A Gottlieb; M Sue Kirkman; Bruce C Marshall; Bonnie Slovis
Journal:  Diabetes Care       Date:  2010-12       Impact factor: 19.112

8.  Preservation of somatostatin secretion in cystic fibrosis patients with diabetes.

Authors:  L R Meacham; D B Caplan; L P McKean; C N Buchanan; J S Parks; F L Culler
Journal:  Arch Dis Child       Date:  1993-01       Impact factor: 3.791

9.  Alpha and beta cell evaluation in patients with thalassaemia intermedia and iron overload.

Authors:  V De Sanctis; M R Gamberini; L Borgatti; G Atti; C Vullo; B Bagni
Journal:  Postgrad Med J       Date:  1985-11       Impact factor: 2.401

10.  Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain.

Authors:  Shihab Hameed; John R Morton; Adam Jaffé; Penny I Field; Yvonne Belessis; Terence Yoong; Tamarah Katz; Charles F Verge
Journal:  Diabetes Care       Date:  2009-11-12       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.